| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Sep 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 532.13 mm | 532.13 mm | 532.13 mm | 532.13 mm | 532.13 mm | 532.13 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 19.55 mm | 16.74 mm | 10.17 mm | 12.40 mm |
| Cash used (since last report) | n/a | n/a | 78.65 mm | 67.33 mm | 40.90 mm | 49.89 mm |
| Cash remaining | n/a | n/a | 453.48 mm | 464.80 mm | 491.24 mm | 482.24 mm |
| Runway (months of cash) | n/a | n/a | 23.2 | 27.8 | 48.3 | 38.9 |
| 13F holders | Current |
|---|---|
| Total holders | 166 |
| Opened positions | 30 |
| Closed positions | 16 |
| Increased positions | 67 |
| Reduced positions | 45 |
| 13F shares | Current |
|---|---|
| Total value | 1.93 tn |
| Total shares | 41.47 mm |
| Total puts | 9.00 k |
| Total calls | 76.80 k |
| Total put/call ratio | 0.1 |
| Largest owners | Shares | Value |
|---|---|---|
| FMR | 4.90 mm | $284.49 bn |
| Pontifax Management 4 G.P. | 4.73 mm | $109.98 mm |
| BlackRock | 2.63 mm | $152.88 bn |
| Alkeon Capital Management | 1.90 mm | $110.19 bn |
| Vanguard | 1.86 mm | $107.80 bn |
| Darwin Global Management | 1.52 mm | $88.48 bn |
| T. Rowe Price | 1.51 mm | $87.95 mm |
| Arkin Moshe | 1.37 mm | $79.29 mm |
| STT State Street | 1.11 mm | $64.67 bn |
| Orbimed Advisors | 1.02 mm | $59.16 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 8 Nov 24 | Yung H. Chyung | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 67.91 | 110,000 | 7.47 mm | 110,000 |
| 13 Aug 24 | Orbimed Advisors | Common Stock | Sell | Dispose S | Yes | No | 44.01 | 29,400 | 1.29 mm | 119,522 |
| 13 Aug 24 | Orbimed Advisors | Common Stock | Sell | Dispose S | Yes | No | 44.01 | 220,600 | 9.71 mm | 899,212 |
| 13 Aug 24 | Gordon Carl L | Common Stock | Sell | Dispose S | Yes | No | 44.01 | 29,400 | 1.29 mm | 119,522 |
| 13 Aug 24 | Gordon Carl L | Common Stock | Sell | Dispose S | Yes | No | 44.01 | 220,600 | 9.71 mm | 899,212 |
| 3 Jun 24 | Jean Jacques Bienaime | Stock Option Common Stock | Grant | Acquire A | No | No | 48.67 | 17,600 | 856.59 k | 17,600 |
